196 related articles for article (PubMed ID: 37119046)
21. Inhibition of proliferation, invasion, and migration of prostate cancer cells by downregulating elongation factor-1alpha expression.
Zhu G; Yan W; He HC; Bi XC; Han ZD; Dai QS; Ye YK; Liang YX; Wang J; Zhong W
Mol Med; 2009; 15(11-12):363-70. PubMed ID: 19707524
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
[TBL] [Abstract][Full Text] [Related]
23. Reciprocal regulation of long noncoding RNAs THBS4‑003 and THBS4 control migration and invasion in prostate cancer cell lines.
Liu J; Cheng G; Yang H; Deng X; Qin C; Hua L; Yin C
Mol Med Rep; 2016 Aug; 14(2):1451-8. PubMed ID: 27357608
[TBL] [Abstract][Full Text] [Related]
24. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4.
Chang S; Sun G; Zhang D; Li Q; Qian H
Cell Death Dis; 2020 Jul; 11(7):592. PubMed ID: 32719361
[TBL] [Abstract][Full Text] [Related]
25. Spalt-Like Protein 4 (SALL4) Promotes Angiogenesis by Activating Vascular Endothelial Growth Factor A (VEGFA) Signaling.
Sun J; Zhao Z; Zhang W; Tang Q; Yang F; Hu X; Liu C; Song B; Zhang B; Wang H
Med Sci Monit; 2020 Mar; 26():e920851. PubMed ID: 32116289
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA‑195‑5p is associated with cell proliferation, migration and invasion in prostate cancer and targets MIB1.
Chen B; Bai G; Ma X; Tan L; Xu H
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34698358
[TBL] [Abstract][Full Text] [Related]
27. The role of WNT10B in normal prostate gland development and prostate cancer.
Madueke I; Hu WY; Hu D; Swanson SM; Vander Griend D; Abern M; Prins GS
Prostate; 2019 Oct; 79(14):1692-1704. PubMed ID: 31433503
[TBL] [Abstract][Full Text] [Related]
28. Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
Peng S; Du T; Wu W; Chen X; Lai Y; Zhu D; Wang Q; Ma X; Lin C; Li Z; Guo Z; Huang H
Urol Oncol; 2018 Aug; 36(8):366.e1-366.e9. PubMed ID: 29903461
[TBL] [Abstract][Full Text] [Related]
29. [High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer].
Yang M; Zhu X; Shen Y; He Q; Qin Y; Shao Y; Yuan L; Ye H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1109-1118. PubMed ID: 36073208
[TBL] [Abstract][Full Text] [Related]
30. TAZ is overexpressed in prostate cancers and regulates the proliferation, migration and apoptosis of prostate cancer PC3 cells.
Lin M; Bu C; He Q; Gu J; Wang H; Feng N; Jiang SW
Oncol Rep; 2020 Aug; 44(2):747-756. PubMed ID: 32468018
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy.
Zeng X; Hu Z; Wang Z; Tao J; Lu T; Yang C; Lee B; Ye Z
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):119-25. PubMed ID: 24418912
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-33b suppresses the proliferation and metastasis of hepatocellular carcinoma cells through the inhibition of Sal-like protein 4 expression.
Tian Q; Xiao Y; Wu Y; Liu Y; Song Z; Gao W; Zhang J; Yang J; Zhang Y; Guo T; Dai F; Sun Z
Int J Mol Med; 2016 Nov; 38(5):1587-1595. PubMed ID: 28026002
[TBL] [Abstract][Full Text] [Related]
33. Dual-Regulated Mechanism of EZH2 and KDM6A on SALL4 Modulates Tumor Progression via Wnt/β-Catenin Pathway in Gastric Cancer.
Ren L; Deng H; Jiang Y; Liu C
Dig Dis Sci; 2023 Apr; 68(4):1292-1305. PubMed ID: 36877334
[TBL] [Abstract][Full Text] [Related]
34. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
[TBL] [Abstract][Full Text] [Related]
35. Silencing
Xiao L; Peng H; Yan M; Chen S
DNA Cell Biol; 2021 Nov; 40(11):1445-1455. PubMed ID: 34767732
[No Abstract] [Full Text] [Related]
36. Suppression of cathepsin a inhibits growth, migration, and invasion by inhibiting the p38 MAPK signaling pathway in prostate cancer.
Park S; Kwon W; Park JK; Baek SM; Lee SW; Cho GJ; Ha YS; Lee JN; Kwon TG; Kim MO; Ryoo ZY; Han SH; Han JE; Choi SK
Arch Biochem Biophys; 2020 Jul; 688():108407. PubMed ID: 32407712
[TBL] [Abstract][Full Text] [Related]
37. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
[TBL] [Abstract][Full Text] [Related]
38. Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression.
Shajari N; Davudian S; Kazemi T; Mansoori B; Salehi S; Khaze Shahgoli V; Shanehbandi D; Mohammadi A; Duijf PHG; Baradaran B
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1495-1504. PubMed ID: 28889753
[TBL] [Abstract][Full Text] [Related]
39. PCGEM1 promotes proliferation, migration and invasion in prostate cancer by sponging miR-506 to upregulate TRIAP1.
Liu H; He X; Li T; Qu Y; Xu L; Hou Y; Fu Y; Wang H
BMC Urol; 2022 Feb; 22(1):14. PubMed ID: 35109849
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of PARVA promotes metastasis by modulating integrin-linked kinase activity and regulating MAPK/ERK and MLC2 signaling in prostate cancer.
Huang C; Shen Q; Song G; He S; Zhou L
Transl Androl Urol; 2021 Feb; 10(2):915-928. PubMed ID: 33718092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
